Literature DB >> 18037193

2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice.

Charles V Pollack1, Eugene Braunwald.   

Abstract

The American College of Cardiology and American Heart Association have updated their guidelines for the management of non-ST-segment-elevation acute coronary syndrome for the first time since 2002. In the interim, several important studies affecting choices of therapy potentially begun in the emergency department have been completed, and care patterns have changed and matured significantly. In this review, we present the new recommendations that are pertinent to emergency medicine practice and comment on their potential implementation into an evidence-based, multidisciplinary approach to the evaluation and management of this challenging patient population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037193     DOI: 10.1016/j.annemergmed.2007.09.004

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  26 in total

1.  Diagnostic importance of platelet parameters in patients with acute coronary syndrome admitted to a tertiary care hospital in southwest region, Saudi Arabia.

Authors:  Abdullah S Assiri; Abdul-Moneim Jamil; Ahmed A Mahfouz; Zizi S Mahmoud; Mohamed Ghallab
Journal:  J Saudi Heart Assoc       Date:  2011-10-20

2.  Recognition and management of complications during moderate and deep sedation. Part 2: cardiovascular considerations.

Authors:  Daniel E Becker; Daniel A Haas
Journal:  Anesth Prog       Date:  2011

3.  Emergency drug kits: pharmacological and technical considerations.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2014

4.  Effects of adding intravenous nicorandil to standard therapy on cardiac sympathetic nerve activity and myocyte dysfunction in patients with acute decompensated heart failure.

Authors:  Shu Kasama; Takuji Toyama; Ryuichi Funada; Noriaki Takama; Norimichi Koitabashi; Shuichi Ichikawa; Yasuyuki Suzuki; Naoya Matsumoto; Yuichi Sato; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-30       Impact factor: 9.236

5.  Establishment of a hybrid risk model to predict major cardiac adverse events in patients with non-ST-elevation acute coronary syndromes.

Authors:  Ning Zhang; Wenxian Liu
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

6.  Acute heart failure guidelines: moving in the right direction?

Authors:  Sean Collins; W Frank Peacock; Joann Lindenfeld
Journal:  Ann Emerg Med       Date:  2010-09-22       Impact factor: 5.721

Review 7.  Puerarin injection for treatment of unstable angina pectoris: a meta-analysis and systematic review.

Authors:  Zhisheng Gao; Baozhu Wei; Cheng Qian
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  Relationship Between Continuity of Ambulatory Care and Risk of Emergency Department Episodes Among Older Adults.

Authors:  David J Nyweide; Julie P W Bynum
Journal:  Ann Emerg Med       Date:  2016-08-09       Impact factor: 5.721

9.  A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes.

Authors:  Ivan Gornik; Ana Vujaklija-Brajkovic; Ivana Pavlic Renar; Vladimir Gasparovic
Journal:  Crit Care       Date:  2010-07-08       Impact factor: 9.097

10.  Long-Term clinical outcomes according to initial management and thrombolysis in myocardial infarction risk score in patients with acute non-ST-segment elevation myocardial infarction.

Authors:  Hae Chang Jeong; Youngkeun Ahn; Myung Ho Jeong; Shung Chull Chae; Seung Ho Hur; Taek Jong Hong; Young Jo Kim; In Whan Seong; Jei Keon Chae; Jay Young Rhew; In Ho Chae; Myeong Chan Cho; Jang Ho Bae; Seung Woon Rha; Chong Jin Kim; Donghoon Choi; Yang Soo Jang; Junghan Yoon; Wook Sung Chung; Jeong Gwan Cho; Ki Bae Seung; Seung Jung Park
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.